| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥421.8B | ¥403.6B | +4.5% |
| Operating Income | ¥11.9B | ¥-3.4B | +454.5% |
| Ordinary Income | ¥12.6B | ¥-0.8B | +892.1% |
| Net Income | ¥7.7B | ¥-3.5B | +317.3% |
| ROE | 1.0% | -0.4% | - |
FY2026 Q3 results show a strong turnaround with revenue of 42.2B yen (YoY +4.5%), operating income of 1.2B yen (prior year -3.4B yen, representing a swing to profitability of +454.5%), ordinary income of 1.3B yen (prior year -0.8B yen, +892.1%), and net income of 0.8B yen (prior year -3.5B yen, +317.3%). The company successfully returned to profitability across all profit levels after previous year losses, though absolute profit margins remain modest with operating margin at 2.8% and net profit margin at 1.8%. Basic earnings per share reached 8.13 yen compared to prior year losses.
Revenue grew 4.5% to 42.2B yen, driven by solid performance in the Japan segment which increased 22.3% to 18.9B yen in external sales, representing the core business at 44.8% of total revenue. North America sales of 8.3B yen declined slightly by 4.2%, while Europe sales of 11.9B yen decreased 0.0% remaining flat. China segment sales of 3.1B yen contracted significantly by 28.9%, reflecting challenging market conditions in that region. The Japan segment includes sales to Asia and other regions beyond domestic market. Operating income improved dramatically from a loss of 3.4B yen to a profit of 1.2B yen, representing a 15.3B yen positive swing. This improvement was driven by the Japan segment profit rising from 1.1B yen to 2.3B yen, and Europe returning to profitability with 0.3B yen profit versus a prior loss of 0.2B yen. Corporate unallocated costs including basic research expenses and head office administrative costs increased slightly to 1.8B yen from 1.8B yen. Ordinary income of 1.3B yen exceeded operating income by 0.1B yen, indicating modest net non-operating income contribution from financial income and equity method gains. Net income of 0.8B yen reflects an effective tax rate of approximately 42.3%, which significantly compressed bottom-line profitability. No material impairment losses or extraordinary items were reported during the period. This represents a revenue up, profit up pattern with successful return to black ink across all profit levels.
Japan is the core business segment generating 18.9B yen in external sales (44.8% of total revenue) and 2.3B yen in segment profit, with an implied margin of 12.2%. This segment grew strongly at 22.3% YoY and profit more than doubled from 1.1B yen. North America generated 8.3B yen in sales (19.7% of total) with segment profit of 0.2B yen (margin 1.9%), experiencing a decline from prior year profit of 0.5B yen as sales decreased 4.2%. Europe contributed 11.9B yen in sales (28.3% of total) with segment profit of 0.3B yen (margin 2.8%), successfully returning to profitability from a prior year loss of 0.2B yen while sales remained flat. China segment generated 3.1B yen in sales (7.3% of total) with segment profit of 0.5B yen (margin 15.4%), though sales declined sharply by 28.9% from 4.3B yen. The China segment maintains the highest profit margin despite revenue contraction. Material margin differences exist between segments, with China at 15.4%, Japan at 12.2%, Europe at 2.8%, and North America at 1.9%, suggesting varying competitive positions and operational efficiency across geographies.
[Profitability] ROE reached 1.0%, recovering from prior year negative territory but remaining well below satisfactory levels, indicating weak capital efficiency. Operating margin of 2.8% improved significantly from prior year losses but remains thin. Net profit margin of 1.8% reflects the burden of a high effective tax rate of 42.3% which substantially erodes pre-tax profitability. Gross profit margin stood at 29.6%, providing reasonable cushion but compressed by operating expenses. EBIT margin of 2.8% signals operational efficiency challenges. [Cash Quality] Cash and deposits totaled 20.5B yen, providing strong liquidity coverage of 9.3 times short-term debt of 2.2B yen. Working capital efficiency shows significant room for improvement with days sales outstanding of 77 days, days inventory outstanding of 159 days, and cash conversion cycle of 202 days, all indicating extended working capital requirements. [Investment Efficiency] Total asset turnover of 0.39 indicates below-average asset utilization. ROIC remains at warning levels, consistent with low operating margins and extended working capital cycles. Interest coverage ratio of 6.4 times provides adequate debt service capacity with interest expense of 0.2B yen against operating profit of 1.2B yen. [Financial Health] Equity ratio of 71.1% improved slightly from 69.5%, reflecting strong capitalization and conservative financial structure. Current ratio of 394.4% and quick ratio of 376.3% indicate extremely strong short-term liquidity position. Debt-to-equity ratio of 0.15 and debt-to-capital ratio of 13.2% demonstrate minimal financial leverage with total interest-bearing debt of 11.8B yen against equity of 77.6B yen. The liabilities-to-equity ratio of 0.41 confirms low overall indebtedness.
Cash and deposits increased 3.3B yen YoY to 20.5B yen, supporting liquidity despite quarterly cash flow statement data being unavailable. The improved profitability with operating income of 1.2B yen versus prior year loss contributed to cash accumulation. Working capital movements show accounts receivable increased to 8.9B yen, reflecting the 77-day collection cycle, while inventories of 2.2B yen align with the 159-day inventory turnover period. Accounts payable stood at 4.2B yen, providing 34 days of supplier financing. The extended cash conversion cycle of 202 days suggests significant cash tied up in operations despite profitability improvement. Investment securities decreased sharply by 2.1B yen to 2.0B yen, indicating portfolio liquidation that generated investment securities sale gains of 0.1B yen recorded in non-operating income. Short-term liquidity coverage of 9.3 times against short-term borrowings indicates substantial payment capacity. The balance sheet structure with current assets of 48.4B yen against current liabilities of 12.3B yen confirms strong working capital position, though efficiency metrics warrant attention for optimal cash generation.
Ordinary income of 1.3B yen versus operating income of 1.2B yen shows net non-operating contribution of approximately 0.1B yen. This comprises primarily investment securities sale gains of 0.1B yen and financial income, partially offset by interest expense of 0.2B yen. Non-operating income represents 0.2% of revenue, consisting of investment gains and minor financial income components. The sale of investment securities representing a 51.9% reduction in the portfolio to 2.0B yen indicates non-recurring asset monetization that supported earnings. Interest and dividend income along with equity method gains contributed to non-operating results. With an effective tax rate of 42.3%, tax expense of 0.6B yen against pre-tax income of 1.3B yen represents a significant earnings drag above typical corporate rates. The return to profitability is supported by operational improvement in the Japan segment, though low operating margins of 2.8% suggest earnings remain sensitive to volume and cost fluctuations. Without quarterly operating cash flow disclosure, earnings quality assessment is limited, though the improvement from prior year losses to positive net income indicates fundamental business recovery. The extended working capital cycle of 202 days raises questions about the cash-generating quality of reported earnings.
Progress rate versus full-year guidance shows revenue at 74.0% (42.2B yen actual versus 57.0B yen full-year forecast), operating income at 79.4% (1.2B yen versus 1.5B yen forecast), and ordinary income at 83.8% (1.3B yen versus 1.5B yen forecast) through Q3. These progress rates significantly exceed the standard 75% benchmark for nine-month cumulative results, indicating the company is tracking ahead of its full-year guidance. Net income progress of 59.2% (0.8B yen versus 1.3B yen forecast) lags somewhat, reflecting the high effective tax rate impact. Revenue growth of 2.4% and ordinary income growth of 892.1% are guided for the full year. The ahead-of-schedule progress on top-line and operating metrics suggests potential for guidance revision upward or conservative Q4 assumptions embedded in the forecast. The company maintains annual dividend guidance of 10 yen per share.
Annual dividend of 20.0 yen per share is planned, comprising interim dividend of 10.0 yen and year-end dividend of 10.0 yen, maintaining the policy from prior guidance. Based on the current nine-month net income of 0.8B yen annualized and full-year forecast of 1.3B yen, the calculated payout ratio reaches approximately 149% against actual nine-month earnings, though this reflects the timing of cumulative profits. Against the company's full-year net income forecast of 1.3B yen, the dividend commitment of approximately 1.9B yen (assuming shares outstanding near 96 million shares based on equity structure) implies a payout ratio well above 100%, raising sustainability questions. However, with cash and deposits of 20.5B yen and strong liquidity metrics, the company maintains near-term dividend payment capacity. No share buyback activities were disclosed during the period. The total return ratio aligns with the dividend payout given no repurchases. The elevated payout ratio relative to current earnings warrants monitoring for dividend sustainability in the context of working capital requirements and business investment needs.
First, extended working capital cycle of 202 days with receivables collection of 77 days and inventory holding of 159 days creates significant cash flow pressure and ties up approximately 11.1B yen in operating working capital, representing 26% of total assets. This exposes the company to customer payment delays, inventory obsolescence, and demand fluctuations that could rapidly strain liquidity despite current strong cash position. Second, geographic revenue concentration with Japan at 45%, Europe at 28%, and North America at 20% creates exposure to regional economic cycles, with the sharp 28.9% China sales decline demonstrating vulnerability to market-specific downturns. Currency fluctuations across USD, EUR, and CNY can materially impact translated results. Third, the high effective tax rate of 42.3% substantially above standard corporate rates of 30-31% in Japan compresses net profitability and suggests potential unfavorable tax positions, one-time tax adjustments, or structural tax inefficiencies that limit earnings growth and cash available for reinvestment and shareholder returns.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE of 1.0% significantly underperforms the manufacturing industry median of 5.2% (IQR: 3.0%-8.3%, n=100), placing the company in the bottom quartile for capital efficiency. Operating margin of 2.8% trails the industry median of 8.7% (IQR: 5.1%-12.6%, n=100) by 5.9 percentage points, indicating substantial operational efficiency challenges. Net profit margin of 1.8% falls well below the industry median of 6.4% (IQR: 3.3%-9.3%, n=100), reflecting both lower operating profitability and higher tax burden. Financial Health: Equity ratio of 71.1% exceeds the industry median of 63.8% (IQR: 49.4%-74.5%, n=100), demonstrating stronger-than-peer capitalization and conservative financial structure. Current ratio of 394.4% substantially surpasses the industry median of 2.83x (IQR: 2.11x-3.80x, n=82), indicating exceptional liquidity though potentially excessive working capital. Efficiency: Asset turnover of 0.39 underperforms the industry median of 0.58 (IQR: 0.41-0.66, n=100), confirming below-average asset utilization. Receivables turnover of 77 days performs better than the industry median of 82.87 days (IQR: 68.37-113.66, n=99). However, inventory turnover of 159 days significantly exceeds the industry median of 108.81 days (IQR: 49.81-154.58, n=92), highlighting material inventory management inefficiency. Operating working capital cycle of 202 days substantially exceeds the industry median of 108.10 days (IQR: 71.12-142.59, n=99), placing the company among the least efficient in working capital management. Growth: Revenue growth of 4.5% outpaces the industry median of 2.8% (IQR: -1.7%-8.1%, n=100), demonstrating above-median top-line momentum. ※ Industry: Manufacturing sector (100 companies), Comparison: FY2025-Q3, Source: Proprietary analysis
The company achieved a significant turnaround from prior year losses to profitability with revenue growth of 4.5% outpacing industry median of 2.8%, demonstrating operational recovery and market share gains particularly in the core Japan segment which grew 22.3%. However, profitability metrics remain structurally weak with ROE of 1.0% versus industry median of 5.2% and operating margin of 2.8% versus industry median of 8.7%, indicating the recovery remains in early stages with substantial efficiency gaps to close. The working capital cycle of 202 days nearly double the industry median of 108 days represents a critical operational challenge, tying up significant cash resources and limiting free cash flow generation despite strong balance sheet liquidity. With the company tracking 79-84% toward full-year guidance through Q3, ahead of the standard 75% pace, there exists potential for guidance achievement or upside, though the elevated dividend payout ratio near 150% of trailing earnings raises sustainability questions that warrant close monitoring of Q4 results and cash flow generation.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.